Overexpression of human β-defensin 2 promotes growth and invasion during esophageal carcinogenesis

Oncotarget

Volumn 5, Issue 22, 2014, Pages 11333-11344

  Shi, Ni ^a   Jin, Feng ^a   Zhang, Xiaoli ^b   Clinton, Steven K ^a   Pan, Zui ^a   Chen, Tong ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Esophageal squamous cell carcinoma and carcinogenesis; Human defensin 2

Indexed keywords

BETA DEFENSIN 2; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; BETA DEFENSIN; DEFB4A PROTEIN, HUMAN; DIMETHYLNITROSAMINE; MESSENGER RNA; N BENZYL N METHYLNITROSAMINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CARCINOMA CELL; CELL INVASION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; DEFB4 GENE; DISEASE ASSOCIATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; GENE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; TUMOR INVASION; UPREGULATION; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; ANIMAL; BIOSYNTHESIS; CHEMICALLY INDUCED; ESOPHAGUS TUMOR; FISCHER 344 RAT; GENE SILENCING; GENETIC TRANSFECTION; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

ANIMALS; BETA-DEFENSINS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; DIMETHYLNITROSAMINE; ESOPHAGEAL NEOPLASMS; GENE KNOCKDOWN TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; RATS; RATS, INBRED F344; RNA, MESSENGER; TRANSFECTION;

EID: 84917706082     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.2416     Document Type: Article

References (42)

1. Souza RF. Molecular and biologic basis of upper gastrointestinal malignancy-esophageal carcinoma. Surg Oncol Clin N Am. 2002; 11(2):257-272, viii.
2. Freedman ND, Park Y, Subar AF, Hollenbeck AR, Leitzmann MF, Schatzkin A and Abnet CC. Fruit and vegetable intake and esophageal cancer in a large prospective cohort study. Int J Cancer. 2007; 121(12):2753-60.
3. Gao Y, Hu N, Han XY, Ding T, Giffen C, Goldstein AM and Taylor PR. Risk factors for esophageal and gastric cancers in Shanxi Province, China: a case-control study. Cancer Epidemiol. 201; 35(6):e91-9.
4. Abnet CC, Borkowf CB, Qiao YL, Albert PS, Wang E, Merrill AH Jr, Mark SD, Dong ZW, Taylor PR and Dawsey SM. Sphingolipids as biomarkers of fumonisin exposure and risk of esophageal squamous cell carcinoma in china. Cancer Causes Control. 2001; 12(9):821-8.
5. Yu X, Zhang T, Zhang H, Hu A, Hu Y, Guo W and Wang Y. Comparison of lifestyle and living environment among high risk immigrant and low risk host residents: implications for esophageal cancer etiology. Asian Pac J Cancer Prev. 2010; 11(6):1827-31.
6. Oka M, Yamamoto K, Takahashi M, Hakozaki M, Abe T, Iizuka N, Hazama S, Hirazawa K, Hayashi H, Tangoku A, Hirose K, Ishihara T and Suzuki T. (1996) Relationship between serum levels of interleukin 6, various disease parameters and malnutrition in patients with esophageal squamous cell carcinoma. Cancer Res. 56(12):2776-80.
7. National Cancer Institute, DCPC, Surveillance Program, Cancer Statistics Branch, SEER Program, Public Use Data (1973-2002), November 2004 submission; Issued April 2005.
8. Brown LM and Devesa SS. Epidemiologic trends in esophageal and gastric cancer in the United States. Surg Oncol Clin N Am. 2002; 11(2):235-56.
9. Layke JC and Lopez PP. Esophageal cancer: a review and update. Am Fam Physician. 2006 Jun 15; 73(12):2187-94.
10. Wu C, Chang J, Ma B, Miao X, Zhou Y, Liu Y, Li Y, Wu T, Hu Z, Shen H, Jia W, Zeng Y, Lin D and et al. The case-only test for gene-environment interaction is not uniformly powerful: an empirical example. Genet Epidemiol. 2013; 37(4):402-7.
11. Zhao C, Wang I and Lehrer RI. Widespread expression of beta-defensinhBD-1 in human secretory glands and epithelial cells. FEBS Lett. 1995; 396(2-3):319-22.
12. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol. 2003; 3(9):710-20.
13. Joly S, Organ CC, Johnson GK, McCray PB Jr and Guthmiller JM. Correlation between beta-defensin expression and induction profiles in gingival keratinocytes. Mol Immunol. 2005; 42(9):1073-84.
14. Johnston A, Gudjonsson JE, Aphale A, Guzman AM, Stoll SW and Elder JT. EGFR and IL-1 signaling synergistically promote keratinocyte antimicrobial defenses in a differentiation-dependent manner. J Invest Dermatol. 2011; 131(2):329-37.
15. Nakatsuji T, Kao MC, Zhang L, Zouboulis CC, Gallo RL and Huang CM. Sebum free fatty acids enhance the innate immune defense of human sebocytes by upregulating beta-defensin-2 expression. J Invest Dermatol. 2010; 130(4):985-94.
16. Janssens W, Nuytten H, Dupont LJ, Van Eldere J, Vermeire S, Lambrechts D, Nackaerts K, Decramer M, Cassiman JJ and Cuppens H. Genomic copy number determines functional expression of {beta}-defensin 2 in airway epithelial cells and associates with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010; 182(2):163-9.
17. Rahman A, Fahlgren A, Sundstedt C, Hammarström S, Danielsson A and Hammarström ML. Chronic colitis induces expression of ß-defensins in murine intestinal epithelial cells. Clin Exp Immunol. 2011; 163(1): 123-30.
18. Gonzalez-Curiel I, Castañeda-Delgado J, Lopez-Lopez N, Araujo Z, Hernandez-Pando R, Gandara-Jasso B, Macias-Segura N, Enciso-Moreno A and Rivas-Santiago B. Differential expression of antimicrobial peptides in active and latent tuberculosis and its relationship with diabetes mellitus. Hum Immunol. 2011; 72(8):656-62.
19. Abiko Y, Mitamura J, Nishimura M, Muramatsu T, Inoue T, Shimono M and Kaku T. Pattern of expression of beta-defensins in oral squamous cell carcinoma. Cancer Lett. 1999; 143(1):37-43.
20. Kesting MR, Sudhoff H, Hasler RJ, Nieberler M, Pautke C, Wolff KD, Wagenpfeil S, Al-Benna S, Jacobsen F and Steinstraesser L. Psoriasin (S100A7) up-regulation in oral squamous cell carcinoma and its relation to clinicopathologic features. Oral Oncol. 2009; 45(8):731-6.
21. Yoshimoto T, Yamaai T, Mizukawa N, Sawaki K, Nakano M, Yamachika E and Sugahara T. Different expression patterns of beta-defensins in human squamous cell carcinomas. Anticancer Res. 2003; 23(6C):4629-33.
22. Abe S, Miura K, Kinoshita A, Mishima H, Miura S, Yamasaki K, Hasegawa Y, Higashijima A, Jo O, Sasaki K, Yoshida A, Yoshiura K and Masuzaki H. Copy number variation of the antimicrobial-gene, defensin beta 4, is associated with susceptibility to cervical cancer. J Hum Genet. 2013; 58(5):250-3.
23. Kresty LA, Morse MA, Morgan C, Carlton PS, Lu J, Gupta A, Blackwood M and Stoner GD. Chemoprevention of esophageal tumorigenesis by dietary administration of lyophilized black raspberries. Cancer Res. 2001; 61(16):6112-9.
24. Chen T, Hwang H, Rose ME, Nines RG and Stoner GD. Chemopreventive properties of black raspberries in N- nitrosomethylbenzylamine-induced rat esophageal tumorigenesis: down-regulation of cyclooxygenase-2, inducible nitric oxide synthase, and c-Jun. Cancer Res. 2006; 66:2853-9.
25. Chen T, Nines RG, Peschke SM, Kresty LA and Stoner GD. Chemopreventive effects of a selective nitric oxide synthase inhibitor on carcinogen-induced rat esophageal tumorigenesis. Cancer Res. 2004; 64(10):3714-3717.
26. Stoner GD, Qin H, Chen T, Carlton PS, Rose ME, Aziz RM and Dixit R. The effects of L-748706, a selective cyclooxygenase-2 inhibitor, on N- nitrosomethylbenzylamine- induced rat esophageal tumorigenesis. Carcinogenesis. 2005; 26(9):1590-5.
27. Reen RK, Dombkowski AA, Kresty LA, Cukovic D, Mele JM, Salagrama S, Nines R and Stoner GD. Effects of phenylethyl isothiocyanate on early molecular events in N-nitrosomethylbenzylamine-induced cytotoxicity in rat esophagus. Cancer Res. 2007; 67(13):6484-92.
28. Stoner GD, Morrissey DT, Heur YH, Daniel EM, Galati AJ and Wagner SA. Inhibitory effects of phenethyl isothiocyanate on N-nitrosobenzylmethylamine carcinogenesis in the rat esophagus. Cancer Res. 2009; 51(8):2063-8.
29. Jang BC, Lim KJ, Paik JH, Kwon YK, Shin SW, Kim SC, Jung TY, Kwon TK, Cho JW, Baek WK, Kim SP, Suh MH and Suh SI. Up-regulation of human beta-defensin 2 by interleukin-1beta in A549 cells: involvement of PI3K, PKC, p38MAPK, JNK, and NF-kappaB. Biochem Biophys Res Commun. 2004; 320:1026-33.
30. Röhrl J, Yang D, Oppenheim JJ and Hehlgans T. Specific binding and chemotactic activity of mBD4 and its functional orthologue hBD2 to CCR6-expressing cells. J Biol Chem. 2010; 285(10):7028-34.
31. Kawsar HI, Ghosh SK, Hirsch SA, Koon HB, Weinberg A and Jin G. Expression of human beta-defensin-2 in intratumoral vascular endothelium and in endothelial cells induced by transforming growth factor beta. Peptides. 2010; 31(2):195-201.
32. Kreuter A, Skrygan M, Gambichler T, Brockmeyer NH, Stücker M, Herzler C, Potthoff A, Altmeyer P, Pfister H and Wieland U. Human papillomavirus-associated induction of human beta-defensins in anal intraepithelial neoplasia. Br J Dermatol. 2009; 160(6):1197-205.
33. Taccioli C, Chen H, Jiang Y, Liu XP, Huang K, Smalley KJ, Farber JL, Croce CM and Fong LY. Dietary zinc deficiency fuels esophageal cancer development by inducing a distinct inflammatory signature. Oncogene. 2012; 31(42):4550-8.
34. Taccioli C1, Wan SG, Liu CG, Alder H, Volinia S, Farber JL, Croce CM and Fong LY. Zinc replenishment reverses overexpression of the proinflammatory mediator S100A8 and esophageal preneoplasia in the rat. Gastroenterology. 2009; 136(3):953-66.
35. Chen MF, Lu MS, Chen PT, Chen WC, Lin PY and Lee KD. Role of interleukin 1 beta in esophageal squamous cell carcinoma. J Mol Med (Berl). 2012; 90:89-100.
36. Hatata T, Higaki K, Tatebe S, Shomori K and Ikeguchi M. Immunohistochemical study of nuclear factor-κB expression in esophageal squamous cell carcinoma: prognostic significance and sensitivity to treatment with 5-FU. Dis Esophagus. 2012; 25(8):716-22.
37. Zheng ST, Zhang CS, Qin X, Gen YH, Liu T, Sheyhidin I and Lu XM. The status of phosphorylated p38 in esophageal squamous cell carcinoma. Mol Biol Rep. 2012; 39(5): 5315-21.
38. Qin X, Zheng S, Liu T, Liu Q, Liang M, Li X, Sheyhidin I and Lu X. Roles of phosphorylated JNK in esophageal squamous cell carcinomas of kazakh ethnic. Mol Carcinog. 2014; 53(7):526-36.
39. Kim HJ, Jung JR, Kim HJ, Lee SY, Chang IH, Lee TJ, Kim W and Myung SC. Expression of human ß-defensin-2 in the prostate. BJU Int. 2011; 107(1):144-9.
40. Matsuo S, Yamazaki S, Takeshige K and Muta T. Crucial roles of binding sites for NF-kappaB and C/EBPs in IkappaB- zeta-mediated transcriptional activation. Biochem J. 2007; 405(3):605-15.
41. Blagosklonny MV. Oncogenic resistance to growth-limiting conditions. Nat Rev Cancer. 2002; 2(3):221-5.
42. Zhu H, Zhang H, Jin F, Fang M, Huang M, Yang CS, Chen T, Fu L, Pan Z. Elevated Orai1 expression mediates tumor-promoting intracellular Ca2+ oscillations in human esophageal squamous cell carcinoma. Oncotarget. 2014 Apr 17.